Long-term treatment of depression with antidepressants: a systematic narrative review (Q33303427)

25 July 2017

1 reference

title

Long-term treatment of depression with antidepressants: a systematic narrative review (English)

1 reference

25 July 2017

3

Corrado Barbui

1 reference

25 July 2017

4

John R Geddes

1 reference

25 July 2017

Toshi A Furukawa

1

1 reference

25 July 2017

Andrea Cipriani

series ordinal

2

1 reference

25 July 2017

language of work or name

English

0 references

publication date

1 September 2007

1 reference

Canadian Journal of Psychiatry

25 July 2017

published in

1 reference

25 July 2017

volume

52

1 reference

25 July 2017

issue

9

1 reference

25 July 2017

page(s)

545-552

1 reference

Metareview on short-term effectiveness and safety of antidepressants for depression: an evidence-based approach to inform clinical practice.

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200902

When should a trial of fluoxetine for major depression be declared failed?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200902

Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200902

Course of depressive symptoms over follow-up. Findings from the National Institute of Mental Health Treatment of Depression Collaborative Research Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200902

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200902

Benefits from mianserin augmentation of fluoxetine in patients with major depression non-responders to fluoxetine alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200902

Strategies for managing depression refractory to selective serotonin reuptake inhibitor treatment: a survey of clinicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200902

Does increasing dose improve efficacy in patients with poor antidepressant response: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200902

Is dose escalation of antidepressants a rational strategy after a medium-dose treatment has failed? A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200902

The antidepressant effect of sertraline is not enhanced by dose titration: results from an outpatient clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200902

Treatment strategies in patients with major depression not responding to first-line sertraline treatment. A randomised study of extended duration of treatment, dose increase or mianserin augmentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200902

Dose escalation for insufficient response to standard-dose selective serotonin reuptake inhibitors in major depressive disorder: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200902

Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200902

A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200902

Treatment strategy in depression. I. Non-tricyclic and selective reuptake inhibitors in resistant depression: a double-blind partial crossover study on the effects of oxaprotiline and fluvoxamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200902

A double-blind, placebo-controlled study of antidepressant augmentation with mirtazapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200902

Effectiveness of antidepressants. Meta-analysis of dose-effect relationships in randomised clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200902

Meta-analysis of effects and side effects of low dosage tricyclic antidepressants in depression: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200902

Lithium augmentation therapy in refractory depression-update 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200902

Triiodothyronine augmentation in the treatment of refractory depression. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200902

A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200902

Randomised controlled trials investigating pharmacological and psychological interventions for treatment-refractory depression. Systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200902

Combined treatment with sertraline and liothyronine in major depression: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200902

Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200902

Extended-release venlafaxine in relapse prevention for patients with major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200902

Prevention of relapse following cognitive therapy vs medications in moderate to severe depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200902

A placebo-controlled, randomized withdrawal study of sertraline for major depressive disorder in Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200902

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200902

Can we individualize the 'number needed to treat'? An empirical study of summary effect measures in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200902

10.1177/070674370705200902

21 January 2018

Identifiers

DOI

1 reference

25 July 2017

1 reference